Simon Ekman

6.2k total citations · 1 hit paper
116 papers, 4.2k citations indexed

About

Simon Ekman is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Simon Ekman has authored 116 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Pulmonary and Respiratory Medicine, 58 papers in Oncology and 37 papers in Molecular Biology. Recurrent topics in Simon Ekman's work include Lung Cancer Treatments and Mutations (63 papers), Lung Cancer Research Studies (31 papers) and Lung Cancer Diagnosis and Treatment (26 papers). Simon Ekman is often cited by papers focused on Lung Cancer Treatments and Mutations (63 papers), Lung Cancer Research Studies (31 papers) and Lung Cancer Diagnosis and Treatment (26 papers). Simon Ekman collaborates with scholars based in Sweden, United Kingdom and United States. Simon Ekman's co-authors include Raffaele Califano, Sanjay Popat, Matteo Giaj Levra, Solange Peters, Silvia Novello, Suresh Senan, Tanja Čufer, Martin Reck, Keith M. Kerr and Fabrice Barlési and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Simon Ekman

114 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2016 1.9k citations Raffaele Califano, Simon Ekman et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simon Ekman Sweden	25	2.5k	2.2k	1.4k	1.0k	381	116	4.2k
Willemijn S.M.E. Theelen Netherlands	16	3.3k 1.3×	3.0k 1.4×	998 0.7×	873 0.9×	385 1.0×	33	4.4k
Ernest Nadal Spain	34	1.8k 0.7×	1.8k 0.8×	1.5k 1.1×	815 0.8×	361 0.9×	169	3.6k
Christina S. Baik United States	27	1.8k 0.7×	2.1k 1.0×	1.3k 0.9×	685 0.7×	339 0.9×	116	3.5k
Vienna Ludovini Italy	33	2.0k 0.8×	2.1k 1.0×	1.3k 1.0×	900 0.9×	205 0.5×	102	3.5k
Przemyslaw Twardowski United States	29	2.4k 1.0×	2.2k 1.0×	1.6k 1.1×	1.2k 1.2×	261 0.7×	113	4.3k
Xiuning Le United States	32	2.0k 0.8×	1.8k 0.8×	1.3k 0.9×	619 0.6×	235 0.6×	168	3.5k
Rita Chiari Italy	36	2.4k 1.0×	2.6k 1.2×	1.4k 1.0×	900 0.9×	452 1.2×	140	4.2k
Manuel Cobo Spain	30	3.4k 1.4×	3.6k 1.7×	1.3k 1.0×	1.1k 1.1×	565 1.5×	219	5.3k
Tina Cascone United States	30	1.6k 0.6×	1.8k 0.8×	1.4k 1.0×	684 0.7×	331 0.9×	104	3.4k
Noriko Yanagitani Japan	37	2.0k 0.8×	1.9k 0.9×	1.9k 1.4×	833 0.8×	252 0.7×	171	4.3k

Countries citing papers authored by Simon Ekman

Since Specialization

Citations

This map shows the geographic impact of Simon Ekman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Ekman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Ekman more than expected).

Fields of papers citing papers by Simon Ekman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Ekman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Ekman. The network helps show where Simon Ekman may publish in the future.

Co-authorship network of co-authors of Simon Ekman

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Ekman. A scholar is included among the top collaborators of Simon Ekman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Ekman. Simon Ekman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Xun, Yong Shi, Boxi Zhang, et al.. (2025). Chaperone-mediated autophagy regulates the metastatic state of mesenchymal tumors. EMBO Molecular Medicine. 17(4). 747–774. 1 indexed citations

Isaksson, Johan, Tomas Hansen, Georg Holgersson, et al.. (2025). Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer—a retrospective cohort study. Translational Lung Cancer Research. 14(6). 1972–1985.

Tsakonas, Georgios, Per Hydbring, Kenbugul Jatta, et al.. (2024). Treatment of metastatic ALK-positive non-small cell lung cancer: real-world outcomes in a single center study. Translational Lung Cancer Research. 13(11). 2918–2933. 1 indexed citations

Ekman, Simon, Zsolt Cselényi, Andrea Varrone, et al.. (2023). Brain exposure of osimertinib in patients with epidermal growth factor receptor mutation non‐small cell lung cancer and brain metastases: A positron emission tomography and magnetic resonance imaging study. Clinical and Translational Science. 16(6). 955–965. 7 indexed citations

Tsakonas, Georgios, et al.. (2023). Safety and efficacy of immune checkpoint blockade in patients with advanced nonsmall cell lung cancer and brain metastasis. International Journal of Cancer. 153(9). 1556–1567. 8 indexed citations

Ekman, Simon, Florian Guisier, Cheryl Ho, et al.. (2023). 1381P TOGETHER: Pooled real-world datasets of METex14 skipping NSCLC and adjusted comparison of upfront (chemo-)immunotherapy with tepotinib from VISION. Annals of Oncology. 34. S792–S793. 3 indexed citations

Brustugun, Odd Terje, et al.. (2022). Ras-Related Protein Rab-32 and Thrombospondin 1 Confer Resistance to the EGFR Tyrosine Kinase Inhibitor Osimertinib by Activating Focal Adhesion Kinase in Non-Small Cell Lung Cancer. Cancers. 14(14). 3430–3430. 6 indexed citations

Alexeyenko, Andrey, Odd Terje Brustugun, Radosveta Gencheva, et al.. (2022). Plasma RNA profiling unveils transcriptional signatures associated with resistance to osimertinib in EGFR T790M positive non-small cell lung cancer patients. Translational Lung Cancer Research. 11(10). 2064–2078. 4 indexed citations

Guo, Kai, Zhiqiang Ma, Yujiao Zhang, et al.. (2022). HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway. Journal of Experimental & Clinical Cancer Research. 41(1). 91–91. 40 indexed citations

10.

Franzén, Bo, Kristina Viktorsson, Vitali Grozman, et al.. (2021). Multiplex immune protein profiling of fine‐needle aspirates from patients with non‐small‐cell lung cancer reveals signatures associated with PD‐L1 expression and tumor stage. Molecular Oncology. 15(11). 2941–2957. 10 indexed citations

11.

Helland, Åslaug, Simon Ekman, Anders Mellemgaard, et al.. (2020). Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study). Lung Cancer. 143. 27–35. 43 indexed citations

12.

Ekman, Simon, Andrea Varrone, Aurelija Jučaitė, et al.. (2019). P2.14-33 An Open-Label PET-MRI Study to Determine Brain Exposure of Osimertinib in Patients with EGFR Mutant NSCLC and CNS Metastases. Journal of Thoracic Oncology. 14(10). S842–S842. 1 indexed citations

13.

Tsakonas, Georgios, Johan Botling, Patrick Micke, et al.. (2019). c-MET as a biomarker in patients with surgically resected non-small cell lung cancer. Lung Cancer. 133. 69–74. 24 indexed citations

14.

Durand‐Zaleski, Isabelle, Paul Baas, David Chao, et al.. (2017). I-O Optimise: Developing A Unique Multinational Real-World Evidence-Based Research Platform In Oncology. Value in Health. 20(9). A742–A743. 1 indexed citations

15.

Dimberg, Lina Y., Anna Dimberg, Mårten Fryknäs, et al.. (2012). Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma. BMC Cancer. 12(1). 318–318. 19 indexed citations

16.

Wu, Xuping, Håkan Hedman, Michael Bergqvist, et al.. (2011). Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity. Acta Oncologica. 51(1). 69–76. 17 indexed citations

17.

Micke, Patrick, Karolina Edlund, Lars Holmberg, et al.. (2011). Gene Copy Number Aberrations Are Associated with Survival in Histologic Subgroups of Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 6(11). 1833–1840. 47 indexed citations

18.

Agnarsdóttir, Margrét, Linda Sooman, Sara Strömberg, et al.. (2010). SOX10 expression in superficial spreading and nodular malignant melanomas. Melanoma Research. 20(6). 468–478. 26 indexed citations

19.

Göransson, Hanna, Karolina Edlund, Maria Rydåker, et al.. (2009). Quantification of Normal Cell Fraction and Copy Number Neutral LOH in Clinical Lung Cancer Samples Using SNP Array Data. PLoS ONE. 4(6). e6057–e6057. 17 indexed citations

20.

Ekman, Simon, et al.. (1999). Increased mitogenicity of an αβ heterodimeric PDGF receptor complex correlates with lack of RasGAP binding. Oncogene. 18(15). 2481–2488. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact